Evidence map›Paper›PMID 30562347›Full record

SynthesisPLoS medicine2018

Effectiveness and treatment moderators of internet interventions for adult problem drinking: An individual patient data meta-analysis of 19 randomised controlled trials.

Heleen Riper, Adriaan Hoogendoorn, Pim Cuijpers, Eirini Karyotaki, Nikolaos Boumparis, Adriana Mira, Gerhard Andersson, Anne H Berman, Nicolas Bertholet, Gallus Bischof and 20 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in PLoS medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Psycho-oncology · 2020
    Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Heleen RiperDepartment of Clinical, Neuro- and Developmental Psychology, VU University, Amsterdam, the Netherlands.ORCID 0000-0002-8144-8901
Adriaan HoogendoornDepartment of Psychiatry, VU University Medical Centre, Amsterdam, the Netherlands.ORCID 0000-0003-4784-0712
Pim CuijpersDepartment of Clinical, Neuro- and Developmental Psychology, VU University, Amsterdam, the Netherlands.ORCID 0000-0001-5497-2743
Eirini KaryotakiDepartment of Clinical, Neuro- and Developmental Psychology, VU University, Amsterdam, the Netherlands.
Nikolaos BoumparisDepartment of Clinical, Neuro- and Developmental Psychology, VU University, Amsterdam, the Netherlands.ORCID 0000-0002-3693-0168
Adriana MiraDepartment of Psychology and Technology, Universitat Jaume I, Castellon, Spain.
Gerhard AnderssonDepartment of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden.
Anne H BermanCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-7709-0230
Nicolas BertholetAlcohol Treatment Centre, Department of Community Medicine and Health, Lausanne University Hospital, Lausanne, Switzerland.ORCID 0000-0001-5064-6377
Gallus BischofDepartment of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.ORCID 0000-0003-0432-5497
Matthijs BlankersArkin Mental Health Care, Department of Research, Amsterdam, the Netherlands.
Brigitte BoonAcademy Het Dorp, Arnhem, the Netherlands.
Leif BoßDepartment of Health Psychology and Applied Biological Psychology, Institute of Psychology, Leuphana University of Lüneburg, Lüneburg, Germany.ORCID 0000-0001-9012-0839
Håvar BrendryenNorwegian Centre for Addiction Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
John CunninghamCentre for Addiction and Mental Health, University of Toronto, Ontario, Canada Department of Psychiatry and Department of Psychology, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-0668-5982
David EbertDepartment of Clinical Psychology and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Anders HansenStrategic Research and Development Support, Metropolitan University College, Copenhagen, Denmark.ORCID 0000-0001-6777-2257
Reid HesterResearch Division, Behavior Therapy Associates, Albuquerque, New Mexico, United States of America.ORCID 0000-0001-6015-2856
Zarnie KhadjesariSchool of Health Sciences, University of East Anglia, Norwich, United Kingdom.ORCID 0000-0002-2958-9555
Jeannet KramerTrimbos Institute-Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands.
Elizabeth MurrayHealth Service and Population Research Department, Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Marloes PostelDepartment of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands.
Daniela SchulzCAPHRI School for Public Health and Primary Care, Department of Health Promotion, Maastricht University, Maastricht, the Netherlands.ORCID 0000-0002-1016-432X
Kristina SinadinovicCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-3446-2134
Brian SuffolettoDepartment of Emergency Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Christopher SundströmInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.ORCID 0000-0003-4237-7159
Hein de VriesCAPHRI School for Public Health and Primary Care, Department of Health Promotion, Maastricht University, Maastricht, the Netherlands.
Paul WallaceeHealth Unit, Research Department of Primary Care and Population Health, University College London, Royal Free Hospital, London, United Kingdom.
Reinout W WiersAddiction Development and Psychopathology (ADAPT) Laboratory, Department of Psychology, University of Amsterdam, the Netherlands.
Johannes H SmitDepartment of Psychiatry, VU University Medical Centre, Amsterdam, the Netherlands.ORCID 0000-0002-2062-8378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFace-to-face brief interventions for problem drinking are effective, but they have found limited implementation in routine care and the community. Internet-based interventions could overcome this treatment gap. We investigated effectiveness and moderators of treatment outcomes in internet-based interventions for adult problem drinking (iAIs). METHODS AND

findingsSystematic searches were performed in medical and psychological databases to 31 December 2016. A one-stage individual patient data meta-analysis (IPDMA) was conducted with a linear mixed model complete-case approach, using baseline and first follow-up data. The primary outcome measure was mean weekly alcohol consumption in standard units (SUs, 10 grams of ethanol). Secondary outcome was treatment response (TR), defined as less than 14/21 SUs for women/men weekly. Putative participant, intervention, and study moderators were included. Robustness was verified in three sensitivity analyses: a two-stage IPDMA, a one-stage IPDMA using multiple imputation, and a missing-not-at-random (MNAR) analysis. We obtained baseline data for 14,198 adult participants (19 randomised controlled trials [RCTs], mean age 40.7 [SD = 13.2], 47.6% women). Their baseline mean weekly alcohol consumption was 38.1 SUs (SD = 26.9). Most were regular problem drinkers (80.1%, SUs 44.7, SD = 26.4) and 19.9% (SUs 11.9, SD = 4.1) were binge-only drinkers. About one third were heavy drinkers, meaning that women/men consumed, respectively, more than 35/50 SUs of alcohol at baseline (34.2%, SUs 65.9, SD = 27.1). Post-intervention data were available for 8,095 participants. Compared with controls, iAI participants showed a greater mean weekly decrease at follow-up of 5.02 SUs (95% CI -7.57 to -2.48, p < 0.001) and a higher rate of TR (odds ratio [OR] 2.20, 95% CI 1.63-2.95, p < 0.001, number needed to treat [NNT] = 4.15, 95% CI 3.06-6.62). Persons above age 55 showed higher TR than their younger counterparts (OR = 1.66, 95% CI 1.21-2.27, p = 0.002). Drinking profiles were not significantly associated with treatment outcomes. Human-supported interventions were superior to fully automated ones on both outcome measures (comparative reduction: -6.78 SUs, 95% CI -12.11 to -1.45, p = 0.013; TR: OR = 2.23, 95% CI 1.22-4.08, p = 0.009). Participants treated in iAIs based on personalised normative feedback (PNF) alone were significantly less likely to sustain low-risk drinking at follow-up than those in iAIs based on integrated therapeutic principles (OR = 0.52, 95% CI 0.29-0.93, p = 0.029). The use of waitlist control in RCTs was associated with significantly better treatment outcomes than the use of other types of control (comparative reduction: -9.27 SUs, 95% CI -13.97 to -4.57, p < 0.001; TR: OR = 3.74, 95% CI 2.13-6.53, p < 0.001). The overall quality of the RCTs was high; a major limitation included high study dropout (43%). Sensitivity analyses confirmed the robustness of our primary analyses.

conclusionTo our knowledge, this is the first IPDMA on internet-based interventions that has shown them to be effective in curbing various patterns of adult problem drinking in both community and healthcare settings. Waitlist control may be conducive to inflation of treatment outcomes.

Indexed as

Data AnalysisInternetAdultAlcohol DrinkingAlcoholismFemaleHumansMaleRandomized Controlled Trials as TopicTherapy, Computer-AssistedTreatment Outcome

Identifiers

PMID30562347
PMCPMC6298657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.